Date: 10.11.2017
Summary:
A French company is developing a novel molecule to be used as a first or second line in the treatment of chemoresistant cancers.
The company is looking for technical cooperation agreements with biotech and pharmaceutical partners with complementary expertise.
Reference: TRFR20170807001
Country: France
Submitted: 10. 11. 2017
Keywords
Technology: Cytology-Cancerology-Oncology, Medical Research, Biology / Biotechnology
Market: Oncology, Pharmaceuticals/fine chemicals
NACE: Research and experimental development on biotechnology
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotech Jobs - Biotechnology jobs at bio.com
Biotechnology events no 8 - Page 8 of our database of biotechnology events
Deadly bacteria show thirst for human blood: Research outlines the phenomenon of bacterial vampirism
Bacteria-filled living dressing could help heal chronic wounds